Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–23. https://doi.org/10.1111/epi.13121. (In eng).
Vossler DG. First Seizures, Acute Repetitive, Seizures, Status Epilepticus. Continuum (Minneap Minn). 2025;31(1):Epilepsy95-124. https://doi.org/10.1212/cont.0000000000001530.
Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Current concepts in neurology: management of status epilepticus. N Engl J Med. 1982;306(22):1337–40. https://doi.org/10.1056/NEJM198206033062205.
Article CAS PubMed Google Scholar
Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA. 1993;270(7):854–9. https://doi.org/10.1001/jama.1993.03510070076040.
Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–18. https://doi.org/10.1093/brain/awr215. (In eng).
Marini C, Rosati A, Fusco L, et al. Genetic Etiologies of Epilepsies With Status Epilepticus: Insights From the Italian Pediatric Status Epilepticus Group Cohort. Neurology. 2026;106(8):e214791. https://doi.org/10.1212/WNL.0000000000214791.
Pang EW, Lawn ND, Lee J, Dunne JW. Mortality after a first-ever unprovoked seizure. Epilepsia. 2023;64(5):1266–77. https://doi.org/10.1111/epi.17567.
Calonge Q, Hanin A, Januel E, et al. Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11-year nationwide study. Epilepsia. 2026;67(1):213–28. https://doi.org/10.1111/epi.18627.
Calonge Q, Guinebretiere O, Nedelec T, et al. Recurrence and Mortality After a First Status Epilepticus: A Retrospective Nationwide Study From the French National Health Data System. Neurology. 2025;104(12):e213693. https://doi.org/10.1212/WNL.0000000000213693.
Trinka E, Rainer LJ, Granbichler CA, Zimmermann G, Leitinger M. Mortality, and life expectancy in Epilepsy and Status epilepticus-current trends and future aspects. Front Epidemiol. 2023;3(3):1081757. https://doi.org/10.3389/fepid.2023.1081757.
Article PubMed PubMed Central Google Scholar
Woodward MR, Armahizer MJ, Wang TI, Badjatia N, Johnson EL, Gilmore EJ. Status epilepticus in older adults: A critical review. Epilepsia. 2025;66(9):3118–37. https://doi.org/10.1111/epi.18453.
Cornwall CD, Kristensen SB, Ulvin LB, et al. Trajectories of long-term survival after status epilepticus. Epilepsia. 2025;66(8):2790–802. https://doi.org/10.1111/epi.18428.
Article PubMed PubMed Central Google Scholar
Terman SW, Guterman EL, Lin CC, Thompson MP, Burke JF. Hospital variation of outcomes in status epilepticus. Epilepsia. 2024;65(5):1415–27. https://doi.org/10.1111/epi.17927.
Article PubMed PubMed Central Google Scholar
De Stefano P, Baumann SM, Fisch U, et al. Impact of Etiology on Mortality and Recovery in Patients With Status Epilepticus. Neurology. 2026;106(5):e214624. https://doi.org/10.1212/WNL.0000000000214624.
Article PubMed PubMed Central Google Scholar
Fong MWK, Stephens E, Brockington A, et al. Status epilepticus in Auckland, New Zealand: Treatment patterns and determinants of outcome in a prospective population-based cohort. Epilepsia. 2024;65(6):1605–19. https://doi.org/10.1111/epi.17975.
Article CAS PubMed Google Scholar
Nadeem ZA, Kashif MAB, Nadeem A, et al. Temporal Trends and Regional Variations in Mortality of Adults With Status Epilepticus in the United States: A Retrospective Study From 1999 to 2020. Neurology. 2026;106(10):e214939. https://doi.org/10.1212/WNL.0000000000214939.
Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy currents. 2016;16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48. (In eng).
Article PubMed PubMed Central Google Scholar
Gronseth GS, Cox J, Gloss D et al. Clinical Practice Guideline Process Manual. 2017 Edition ed., American Academy of Neurology, 2017.
Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348–55. https://doi.org/10.1111/j.1468-1331.2009.02917.x. (In eng).
Article CAS PubMed Google Scholar
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23. https://doi.org/10.1007/s12028-012-9695-z. (In eng).
Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591–600. https://doi.org/10.1056/NEJMoa1107494.
Article CAS PubMed PubMed Central Google Scholar
Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631–7. https://doi.org/10.1056/NEJMoa002141.
Article CAS PubMed Google Scholar
Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8. https://doi.org/10.1056/NEJM199809173391202. (In eng).
Article CAS PubMed Google Scholar
Cruickshank M, Imamura M, Booth C, et al. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis. Health Technol Assess. 2022;26(20):1–76. https://doi.org/10.3310/RSVK2062.
Article PubMed PubMed Central Google Scholar
Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249(11):1452–4. https://doi.org/10.1001/jama.1983.03330350028021.
Article CAS PubMed Google Scholar
Walker JE, Homan RW, Vasko MR, Crawford IL, Bell RD, Tasker WG. Lorazepam in status epilepticus. Ann Neurol. 1979;6(3):207–13. https://doi.org/10.1002/ana.410060305.
Article CAS PubMed Google Scholar
Vossler DG, Gidal BE. A Summary of Antiseizure Medications Available in the United States. (https://aesnet.org/docs/default-source/pdfs-clinical/42981132_aes_summary_of_antiseizure_medications_available_in_the_united_states_4th_edition_april_2024.pdf?sfvrsn=65016203_1)
Guterman EL, Burke JF, Sporer KA. Prehospital Treatment of Status Epilepticus in the United States. JAMA. 2021;326(19):1970–1. https://doi.org/10.1001/jama.2021.15964.
Article CAS PubMed PubMed Central Google Scholar
Guterman EL, Sanford JK, Betjemann JP, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology. 2020;95(24):e3203-12. https://doi.org/10.1212/WNL.0000000000010913.
Article CAS PubMed PubMed Central Google Scholar
Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421–32. https://doi.org/10.1002/ana.25416.
Article CAS PubMed Google Scholar
Sathe AG, Underwood E, Coles LD, et al. Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia. 2021;62(3):795–806. https://doi.org/10.1111/epi.16825.
Comments (0)